United States of America

Choose your country

Select your country

Did you know? Fujirebio and Covid-19

In a reply to the Covid-19 pandemic impacting the world since early 2020, Fujirebio plays an important role as a healthcare partner, offering various testing solutions that are used across the world today to support fast and trustworthy diagnosis.

Lumipulse^® G KL-6 (Krebs von den Lungen)

Lumipulse® G KL-6 (Krebs von den Lungen)

Lumipulse G CLIA analyzer cartridge close up

LUMIPULSE G1200 fully automated CLEIA analyzer with sample kit package

LUMIPULSE G1200 fully automated CLEIA analyzer - cartridge loading

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of sialylated carbohydrate antigen, KL-6 in serum or plasma.

The assay utilises proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.

You will find more resources about ILDs and the KL-6 biomarker in our dedicated microsite at www.fujirebio.com/kl-6 (opens in a new window).

CE marked

Lumipulse® G KL-6 Immunoreaction Cartridges

Product number 233207

3 × 14 Tests

Contact sales for information and inquiries

Please contact your local Fujirebio representative for the availability of this product in your country.

Click here to navigate

Details
Conditions of sale
Documentation
FAQ
Insights
Related products
Product inquiry

Details

See the LUMIPULSE G1200 working in this video:
Conditions of sale

To read the end user conditions of sale for this product please visit our Resource center.
Documentation

Browse regulatory documents for this product

Create a (free!) eServices account and start browsing all regulatory documentation right away.

Register now or Sign in
Other documents

File

KL-6 Whitepaper (pdf, 378.50 kb)

Extra information

Guidance document on the value of measuring KL-6 in the field of lung diseases.

File

KL-6 Biomarker Information - Physician Leaflet (pdf, 3.71 mb)

File

Lumipulse G Lung Disease Management brochure (pdf, 151.32 kb)
Get access to this section and more

Create a free eServices account now and instantly access multiple digital resources:

Regulatory product documentation

Selected scientific posters

Product leaflets

How-to videos and more…

Register now or Sign in
Insights

Lung disease

Webinar: Lumipulse® G KL-6, the biomarker for routinely assessment of epithelial alveolar damage in pulmonary fibrosis and COVID-19

During this webinar Dr. Francesco Bonella (MD - Center for Interstitial & Rare Lung Disease, Department of Pulmonology, Ruhrlandklinik University...

Oct 19, 2020

Read more

Lung disease

Japanese authorities have chosen Lumipulse® for nasopharyngeal or saliva-based SARS-CoV-2 antigen testing of passengers at their main international airports

Several fully automated and CLEIA-based LUMIPULSE G1200 systems from Fujirebio are right now performing fast, high sensitivity SARS CoV-2 antigen...

Aug 26, 2020

Read more

Lung disease

Can KL-6 be a specific marker of alveolar damage for COVID-19 patients?

There are many reference centers across Europe that have included KL-6 as one of the biomarkers within the COVID-19 protocol to strengthen the battery...

Apr 30, 2020

Read more
FAQ

How does the coronavirus disease Covid-19 impact Fujirebio's operations?

Please see the following statement on the impact of coronavirus disease Covid-19 on the operations of Fujirebio Europe (updated January 19, 2021).
Related products

Lumipulse^® G SARS-CoV-2 Ag

Product number 260340, 231869 -

For in vitro diagnostic (IVD) use with the Lumipulse G system for detection and quantitative measurement of SARS-CoV-2 nucleocapsid protein antigen in human nasopharyngeal swab or saliva. As a diagnostic tool for the confirmation of a SARS-CoV-2 infection.

CE marked

Detail

ESPLINE^® SARS-CoV-2

Product number 231906 -

Immunochromatographic assay for the detection of SARS-CoV-2 antigen directly from nasopharyngeal swab fluid and is intended for use as an aid in the diagnosis of SARS-CoV-2 infection.

CE marked

Detail

iAMP COVID-19 Detection Kit

Product number 80767, 80762 -

Qualitative nucleic acid detection of SARS-CoV-2 (COVID-19) on naso- or oropharyngeal swabs without pre-treatment.

CE marked

Detail

Lumipulse^® G CEA-N (Carcinoembryonic Antigen)

Product number 292662 -

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of carcinoembryonic antigen (CEA) in serum or plasma.

CE marked

Detail

Lumipulse^® G CYFRA (Cytokeratin Subunit 19 Fragment)

Product number 292945 -

Immunoreaction cartridges for in vitro diagnostic use with the LUMIPULSE G System for the quantitative measurement of cytokeratin subunit 19 fragment (CYFRA) in serum or plasma.

CE marked

Detail

Lumipulse^® G Mesothelin

Product number 294192 -

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative determination Soluble Mesothelin Related Peptides (SMRP) in human serum or plasma.

CE marked

Detail

Lumipulse^® G PIVKA-II

Product number 233184 -

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of protein induced vitamin K absence or antagonist-II (PIVKA-II) in serum.

CE marked

Detail

Lumipulse^® G ProGRP (Pro-Gastrin-Releasing Peptide)

Product number 297858 -

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of Pro-gastrin-releasing peptide [ProGRP (31-98)] in serum or plasma.

CE marked

Detail

IL-6 (Interleukin) LPG

Product number 293423 -

For research use with the LUMIPULSE G system for the quantitative measurement of IL-6 in serum or plasma.

For research use only

Detail

Lumipulse^® PIVKA-II and KL-6 Control

Product number 233801 -

Assayed control serum to monitor the precision of laboratory testing procedures for the analysis of PIVKA-II and KL-6 using LUMIPULSE Systems.

CE marked

Detail

Lumipulse^® G SCC (Squamous Cell Carcinoma)

Product number 298411, 235430 -

Immunoreaction cartridges for in vitro diagnostic use with the LUMIPULSE G instruments for the quantitative measurement of squamous cell carcinoma (SCC) antigen in human serum or plasma samples as an aid in the management of patients with squamous cell carcinoma.

CE marked

Detail

LUMIPULSE^® G600II

Product number 703380 -

The LUMIPULSE G600II is the latest member of the Lumipulse G series of chemiluminescent enzyme immunoassay analyzers (CLEIA) from Fujirebio.

CE marked

Detail

LUMIPULSE^® G1200

Product number 232002 -

A robust, mid-sized and fully automated chemiluminescent enzyme immunoassay (CLEIA) system from the already widely successful LUMIPULSE series.

CE marked

Detail
Product inquiry

Salutation

First name

Last name

E-mail

Phone number

Organization / company

Company type

Function / job title

Message or question

Request support for

The provision of your data implies your consent to the processing of your data in our database and, depending on the option you choose, to receiving our monthly newsletter by e-mail.

For more information on how we process your personal data and regarding the rights you have in this respect, we refer to our privacy policy, which we hold at your disposal HERE.

If you no longer wish to receive our newsletter, you have the option to unsubscribe via the ‘unsubscribe’ tool at the bottom of the newsletter. If you want to have your data removed from our database, please contact us at: privacy@fujirebio.com.

Your local distributor(s) for this product

Fujirebio US, Inc.

205 Great Valley Parkway
Malvern, PA 19355
United States

001 877.861.7246
Toll-free: +1 877.861.7246. Hours of operation: Monday to Friday from 8:30am – 5:30pm EST.

Product support
001 877.861.7246

site by D'M&S

Close